Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-22-002830
Filing Date
2022-10-18
Accepted
2022-10-18 16:45:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO THE SCHEDULE 13D sc13da312236004_10182022.htm SC 13D/A 135997
  Complete submission text file 0000921895-22-002830.txt   137521
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Subject) CIK: 0000794172 (see all company filings)

EIN.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-38201 | Film No.: 221316353
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 152 WEST 57TH STREET, 17TH FLOOR NEW YORK CITY NY 10019
Business Address 152 WEST 57TH STREET, 17TH FLOOR NEW YORK CITY NY 10019 (212) 218-8812
Impactive Capital LP (Filed by) CIK: 0001786767 (see all company filings)

EIN.: 000000000
Type: SC 13D/A